The MSC curtain that stops the immune system

被引:80
作者
Caplan, Arnold I. [1 ]
Sorrell, J. Michael [1 ]
机构
[1] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA
关键词
Mesenchymal Stem Cells; Immunomodulatory; Trophic; Pericytes; Cell-based therapy; MESENCHYMAL STEM-CELLS; STROMAL CELLS; PROGENITOR CELLS; ADENOSINE; THERAPY; DIFFERENTIATION; RECEPTORS; RESISTANT; PEPTIDE; ORIGIN;
D O I
10.1016/j.imlet.2015.06.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
We have evolved cellular mechanisms for protecting us from disabling intruders or injuries. The Mesenchymal Stem Cell, MSC, is derived from perivascular cells, pericytes that are liberated from their basement membrane tethers surrounding blood vessels upon injury or inflammation. These site-activated MSCs produce a curtain of immuno-modulation behind which slow and specific tissue regeneration takes place. In addition, the MSC senses the tissue microenvironment and adjusts the curtain and regenerative activity accordingly. This includes the production of antibiotic proteins like LL37 that both kills intruding bacteria on contact, but calls forth macrophage and other members of the hematopoietic system to further medicate the injury site. Indeed, MSCs appear to be local managers of the tissues' innate regenerative potential. Thus, I propose that MSC should denote "Medicinal Signaling Cells" since these cells are "drug stores" for sites of injury or inflammation. (C) 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:136 / 139
页数:4
相关论文
共 62 条
[2]
Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[3]
Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.tea.2011.0036, 10.1089/ten.TEA.2011.0036]
[4]
Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive Pathogens [J].
Allen, Judith E. ;
Wynn, Thomas A. .
PLOS PATHOGENS, 2011, 7 (05)
[5]
Bone Marrow-Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo [J].
Amarnath, Shoba ;
Foley, Jason E. ;
Farthing, Don E. ;
Gress, Ronald E. ;
Laurence, Arian ;
Eckhaus, Michael A. ;
Metais, Jean-Yves ;
Rose, Jeremy J. ;
Hakim, Frances T. ;
Felizardo, Tania C. ;
Cheng, Austin V. ;
Robey, Pamela G. ;
Stroncek, David E. ;
Sabatino, Marianna ;
Battiwalla, Minoo ;
Ito, Sawa ;
Fowler, Daniel H. ;
Barrett, Austin J. .
STEM CELLS, 2015, 33 (04) :1200-1212
[6]
Mesenchymal stem cells: immune evasive, not immune privileged [J].
Ankrum, James A. ;
Ong, Joon Faii ;
Karp, Jeffrey M. .
NATURE BIOTECHNOLOGY, 2014, 32 (03) :252-260
[7]
CD39 and CD73 in immunity and inflammation [J].
Antonioli, Luca ;
Pacher, Pal ;
Vizi, E. Sylvester ;
Hasko, Gyoergy .
TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) :355-367
[8]
The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells [J].
Barry, F ;
Boynton, R ;
Murphy, M ;
Zaia, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (02) :519-524
[9]
Bensidhoum Morad, 2005, Journal de la Societe de Biologie, V199, P337, DOI 10.1051/jbio:2005035
[10]
The role of pericytes in blood-vessel formation and maintenance [J].
Bergers, G ;
Song, S .
NEURO-ONCOLOGY, 2005, 7 (04) :452-464